Literature DB >> 14739556

Lung microvascular adaptation in infants with chronic lung disease.

Donald W Thibeault1, Sherry M Mabry, Michael Norberg, William E Truog, Ikechukwu I Ekekezie.   

Abstract

Microvascular development is critical for normal lung maturation. The aims of this study were (1) to quantitatively and qualitatively assess lung microvascular growth in the human fetus, from 22 to 40 weeks' gestation, and (2) to compare development in these infants to those with mild, moderate and severe chronic lung disease (CLD). Using 1- and 4-microm thick sections and electron microscopy, lungs were morphometrically assessed for surface density of distal air spaces; volume density of parenchymal vessels having an air-blood barrier (ABB); percent of distal air space wall having an ABB, and capillary loading, defined as ABB/mm2 of epithelial surface area. The percent of vessels with ABB increased in controls during development in parallel with increasing lung parenchyma. Infants with severe CLD had fewer ABBs and less capillary loading than controls up to 34 weeks' post-conceptional age (PCA), but by 36-40 weeks, showed catch-up growth. Microvasculature vessel diameter, septal thickness, and air sac diameter at 36-40 weeks' PCA were increased with severe CLD, and vessels were more distant from the air surface. We conclude that infants with severe CLD have both stunted secondary septation and microvascular development, but over time, the primary septal wall adapts by thinning and increasing the number of ABBs, thereby taking on the function of secondary septa. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 14739556     DOI: 10.1159/000076388

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  11 in total

1.  Relationship of structural to functional impairment during alveolar-capillary membrane development.

Authors:  Shawn K Ahlfeld; Yong Gao; Simon J Conway; Robert S Tepper
Journal:  Am J Pathol       Date:  2015-02-03       Impact factor: 4.307

2.  Developmental determinants and changing patterns of respiratory outcomes after preterm birth.

Authors:  Steven H Abman; Simon J Conway
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-03

Review 3.  Assessment of inhibited alveolar-capillary membrane structural development and function in bronchopulmonary dysplasia.

Authors:  Shawn K Ahlfeld; Simon J Conway
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-03-06

4.  Retinoic acid and erythropoietin maintain alveolar development in mice treated with an angiogenesis inhibitor.

Authors:  Su Jin Cho; Caroline L S George; Jeanne M Snyder; Michael J Acarregui
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09-01       Impact factor: 6.914

5.  Partial pulmonary embolization disrupts alveolarization in fetal sheep.

Authors:  Caitlin E Filby; Stuart B Hooper; Megan J Wallace
Journal:  Respir Res       Date:  2010-04-23

6.  Membrane and Capillary Components of Lung Diffusion in Infants with Bronchopulmonary Dysplasia.

Authors:  Daniel V Chang; Santiago J Assaf; Christina J Tiller; Jeffrey A Kisling; Robert S Tepper
Journal:  Am J Respir Crit Care Med       Date:  2016-04-01       Impact factor: 21.405

Review 7.  Animal models of bronchopulmonary dysplasia. The preterm baboon models.

Authors:  Bradley A Yoder; Jacqueline J Coalson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-03       Impact factor: 5.464

Review 8.  Bronchopulmonary dysplasia: an update.

Authors:  Anita Bhandari; Vineet Bhandari
Journal:  Indian J Pediatr       Date:  2007-01       Impact factor: 5.319

9.  Altered pulmonary lymphatic development in infants with chronic lung disease.

Authors:  Emily M McNellis; Sherry M Mabry; Eugenio Taboada; Ikechukwu I Ekekezie
Journal:  Biomed Res Int       Date:  2014-01-02       Impact factor: 3.411

10.  Gestational Age Influences the Early Microarchitectural Changes in Response to Mechanical Ventilation in the Preterm Lamb Lung.

Authors:  Regina B Oakley; David G Tingay; Karen E McCall; Elizabeth J Perkins; Magdy Sourial; Peter A Dargaville; Prue M Pereira-Fantini
Journal:  Front Pediatr       Date:  2019-08-21       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.